Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 5:00 AM ET

Date/Time Source News Release
12/19/2024 06:38 AM EST GlobeNewswire Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
12/11/2024 07:02 AM EST GlobeNewswire Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
12/03/2024 10:03 AM EST Newsfile Ocugen, Inc. (OCGN) Shareholder Notice: Grabar Law Office Investigates Claims on Your Behalf
11/27/2024 07:09 AM EST GlobeNewswire Ocugen CEO to Present at NobleCon20 - Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
11/20/2024 07:30 AM EST GlobeNewswire Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
11/19/2024 07:02 AM EST GlobeNewswire Ocugen Announces Compelling Preliminary Data for OCU410-a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
11/08/2024 06:45 AM EST GlobeNewswire Ocugen Provides Business Update with Third Quarter 2024 Financial Results
11/07/2024 06:30 AM EST GlobeNewswire Ocugen Secures $30 Million in Debt Funding
11/01/2024 08:13 AM EDT Newsfile Attention Ocugen, Inc. (OCGN) Shareholders: Grabar Law Office Investigates Claims on Your Behalf
10/28/2024 06:30 AM EDT GlobeNewswire Ocugen Clinical Showcase Highlighting Progress in Retinal Gene Therapy Clinical Trials in New York City on Tuesday, November 12, 2024
Page

Additional News

As of January 4, 2025 • 5:00 AM ET

Date/Time Source News Release
12/23/2024 09:39 AM EST Zacks 5 Biotech Breakthrough Stocks to Watch in 2025
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Ocugen, Inc.
11/19/2024 10:10 AM EST SeekingAlpha Ocugen reports positive data for OCU400, OCU410
11/14/2024 04:40 PM EST Zacks Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates
11/13/2024 04:00 PM EST InvestorBrandNetwork Shankar Musunuri, CEO of Ocugen Inc. (NASDAQ: OCGN), to Present at NobleCon20
11/08/2024 11:15 AM EST Motley Fool Ocugen (OCGN) Q3 2024 Earnings Call Transcript
11/08/2024 10:18 AM EST SeekingAlpha Ocugen, Inc. (OCGN) Q3 2024 Earnings Call Transcript
11/08/2024 06:55 AM EST SeekingAlpha Ocugen reports Q3 results
11/07/2024 06:00 PM EST SeekingAlpha Here's the major earnings before the open tomorrow
11/07/2024 11:30 AM EST SeekingAlpha Ocugen Q3 2024 Earnings Preview
Page